← Reviews
Open accessFull analysisJun 21, 2026

Microbiota–gut–brain axis and anxiety or depression: bibliometric and visual analysis

This bibliometric study maps publication trends on the MGB axis and mental disorders but provides no efficacy data for any clinical intervention.

Evidence levelDNarrative / animal / in vitro / mechanistic
Study typenarrative_review
Sample1816
Effect directionInsufficient
CertaintyVery low
Clinical applicabilityVery low
Overinterpretation risk1/5 · Low
PICO
PopulationScientific literature indexed in the Web of Science Core Collection on the MGB axis and anxiety or depression
InterventionBibliometric analysis using CiteSpace and VOSviewer (co-citation, co-occurrence, collaborative networks, keyword burst detection)
Comparator
OutcomeAnnual publication volume; Geographic distribution of publications; Author productivity; Institutional productivity; Predominant keywords (co-occurrence)

Summary of findings

OutcomeEffect95% CICertaintyClinical relevanceNotes
Annual publication volumedescriptive count: 1816 articles, continuous annual increase (no statistical test reported)Very low1 studies
Geographic distribution of publicationsdescriptive: China 497/1816 articles (27.37%)Very low1 studies
Author productivitydescriptive: Cryan JF top author, 115 publicationsVery low1 studies
Institutional productivitydescriptive: University College Cork 138/1816 articles (7.60%)Very low1 studies
Predominant keywords (co-occurrence)descriptive: probiotics and inflammation as top co-occurring keywords (no quantitative effect size reported)Very low1 studies

Context

Anxiety and depression affect hundreds of millions of people worldwide. The microbiota–gut–brain axis is an increasingly investigated pathophysiological pathway. Mapping the volume, actors, and dominant themes in the literature guides future research priorities.

What the study showed

A total of 1816 articles were identified, with a continuous annual upward trend. China led with 497 publications (27.37% of the total). The journal Nutrients concentrated 77 articles (4.24%). John F. Cryan was the most prolific author (115 publications) and University College Cork the most productive institution (138 articles; 7.60%). Probiotics and inflammation were the most prominent keywords.

How it was done

Bibliometric review of articles retrieved from the Web of Science Core Collection with no explicitly stated time restriction. CiteSpace and VOSviewer were applied for co-citation network analysis, keyword co-occurrence, and country and institutional collaboration. No PICO-based study selection or clinical data extraction was performed.

Effect magnitude

Not applicable: the study measures no clinical effect of any intervention. Data are descriptive of bibliographic volume and collaboration networks.

Risk of bias

Single data source (Web of Science), excluding Scopus, PubMed, and other databases, which underestimates total production. No standardized risk-of-bias tool (RoB 2, ROBINS-I, or AMSTAR-2) was applied. Bibliometric analysis provides no information on methodological quality, replicability, or clinical validity of included studies.

Interpretation limit

What this study does NOT prove

This study does not prove that any MGB axis intervention reduces anxiety or depression. It establishes no causality, efficacy, safety, or clinical applicability of any therapeutic approach.

In clinical practice

This study provides NO basis for changing clinical practice. It maps the research landscape, not treatment efficacy. Clinicians should consult systematic reviews and RCTs for therapeutic decisions regarding probiotics or MGB axis interventions.

Limitations

Single data source (Web of Science), excluding Scopus, PubMed, and other databases, which underestimates total production. No standardized risk-of-bias tool (RoB 2, ROBINS-I, or AMSTAR-2) was applied. Bibliometric analysis provides no information on methodological quality, replicability, or clinical validity of included studies.

What is still missing

Systematic reviews and meta-analyses of RCTs with standardized clinical outcomes (validated anxiety and depression scales) are needed to translate bibliographic volume into actionable recommendations.

Technical appendix

Version history

  • 1.0 · 2026-06-21 — Auto-generated under Evidence Standard v1.0

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.